´ëÇѼ¼Æ÷º´¸®ÇÐȸ
 
HOME   SITEMAP   CONTACT   ENGLISH    ¤Ó   
> ¼Ò½ÄÁö > ÇÐȸÇà»ç¼Ò½Ä
ÇÐȸÇà»ç¼Ò½Ä
2023³â Á¦35Â÷ °¡À»Çмú´ëȸ

°¡À»Çмú´ëȸ´Â 2023³â 9¿ù 1ÀÏ(±Ý)- 2ÀÏ(Åä) ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ¿¡¼­ ÁøÇàµÇ¾ú½À´Ï´Ù. ¸ðµÎ 325¸í(Àü¹®ÀÇ 211¸í, Àü°øÀÇ 37¸í, ¼¼Æ÷º´¸®»ç 77¸í)ÀÌ µî·ÏÇÏ¿´½À´Ï´Ù.


Ư°­ ¹× ½ÉÆ÷Áö¿ò ³»¿ëÀº ´ÙÀ½°ú °°½À´Ï´Ù.

1) Ư°­

-2023 ´ëÇÑ°©»ó¼±ÇÐȸ °©»ó¼±°áÀý Áø·á ±Ç°í¾È: ¹Ú¿µÁÖ(¼­¿ïÀÇ´ë)


2) ½ÉÆ÷Áö¾ö I: Reporting Systems for Cytopathology: Recent Updates

- The Bethesda System for reporting thyroid cytopathology 3 rd  edition :  ¼Ûµ¿Àº(¿ï»êÀÇ´ë)

- The WHO System for reporting lung cytopathology :  Â÷ÈñÁ¤(¿ï»êÀÇ´ë)

- The WHO System for reporting lymph node cytopathology :  Á¤Çý¶ó(°è¸íÀÇ´ë)

- Updates to the Milan System :  ½Å¼öÁø(¿¬¼¼ÀÇ´ë)


3) ½ÉÆ÷Áö¾ö II: Body Fluid Cytopathology

- The International System (TIS) for reporting serous fluid cytopathology : ÃÖ±ÝÇÏ(¿ø±¤ÀÇ´ë)

- Ancillary tests for effusion cytology : ±è·ç½Ã¾Æ(ÀÎÇÏÀÇ´ë)

- Cerebrospinal fluid (CSF) cytology : ±è¼¼ÈÆ(¿¬¼¼ÀÇ´ë)


ÇÐȸ ÃÑȸ¿¡¼­´Â Çмú»ó ½Ã»óÀÌ ÀÖ¾ú½À´Ï´Ù.

´ë»ó¿¡´Â ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¤¿ä¼Á ȸ¿øÀÌ ¡°Recent Application of Artificial Intelligence in Non-Gynecological Cancer Cytopathology: A Systematic Review. Cancers 2022;14(14):3529 ¡±³í¹®À¸·Î ¼ö»óÇÏ¿´½À´Ï´Ù.


¿ì¼ö»óÀº ¼­¿ï´ëº´¿ø À¯ÇѼ® ȸ¿ø°ú °æºÏ´ëº´¿ø ¹ÚÁö¿µ(B) ȸ¿øÀÌ ¡°Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naïve patients: A single-center study. Cancer Med. 2022;11(11):2193-2203¡± ¡°Strategic significance of low viral load of human papillomavirus in uterine cervical cytology specimens. Diagnostics. 2022;12(8):1855¡± ³í¹®À¸·Î ¼ö»óÇÏ¿´½À´Ï´Ù. 


ÇмúÀå·Á»ó(JPTM¼¼Æ÷³í¹® ÃÖ´Ù°ÔÀç»ó)Àº ¼­¿ï´ëº´¿ø À¯ÇѼ® ȸ¿øÀÌ ¼ö»óÇÏ¿´°í Á¤Ã¥¿¬±¸ºñ´Â »ó°è¹éº´¿ø ±èÇöÁ¤ ȸ¿øÀÌ¡®ÀÎÀ¯µÎ¹ÙÀÌ·¯½º ºñ ÀÇÁ¸¼º ÀڱðæºÎ »óÇÇ ³» ÀÌÇü¼ºÁõ ¹× ¾Ï¿¡¼­ Àڱü¼Æ÷Áø °Ë»ç Áø´ÜÁß¿äµµ Àü±¹Á¶»ç¡¯·Î ¹Þ¾Ò½À´Ï´Ù.


ÃÖ¿ì¼ö Æ÷½ºÅÍ»óÀº ¼ÕÈñ½Â(¼­¿ï¼º¸ðº´¿ø), ¿ì¼öÆ÷½ºÅÍ»óÀº ¿À½ÂÁÖ( ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø), ±èÇöÁ¤(»ó°è¹éº´¿ø), Àå·Á»óÀº ¿À¿µÀç(¼­¿ï¾Æ»êº´¿ø), ÃÖ¼®Áø(ÀÎÇϴ뺴¿ø) ȸ¿ø, ½½¶óÀ̵弼¹Ì³ª Áõ·Ê¿ì¼öÃÊ·Ï»óÀº ¹Ú¼öÈ£(»ï¼º¼­¿ïº´¿ø) ȸ¿øÀÌ ¼ö»óÇÏ¿´½À´Ï´Ù.


2 ÀÏ(Åä)¿¡´Â ÇÑÀÏÇмú´ëȸ(The 20th Korea-Japan Joint Meeting for Diagnostic Cytopathology)°¡ °³ÃֵǾú½À´Ï´Ù. ÀϺ»Ãø Âü¼®ÀÚ´Â 19¸í(Àü¹®ÀÇ 12¸í, ¼¼Æ÷º´¸®»ç 7¸í)À̾ú½À´Ï´Ù.


ÇÑÀÏÇмú´ëȸ 20Áֳ⠱â³ä Ưº° ½ÉÆ÷Áö¿òÀÌ ÀÖ¾ú°í ´ÙÀ½°ú °°Àº ÁÖÁ¦·Î ¹ßÇ¥µÇ¾ú½À´Ï´Ù.

- Past activity summary of JSCC, future task, and hope: Prof. Yukitoshi SATOH (Kitasato University School of Medicine)


- Past activity summary of KSC, future task and hope: Prof. Yoon Jung CHOI (Yongin Severance Hospital)


-  Cytological perspective in the era of cancer genome: Prof. Eiichi MORII (Osaka University)


-  Clinicocytopathologic analysis of 574 pericardial effusion: Prof. Joon Seon SONG (Asan Medical Center)


35_°¡¿ï.jpg

(04195) ¼­¿ï½Ã ¸¶Æ÷±¸ ¸¸¸®Àç·Î 14, 1508È£ (°ø´öµ¿, Çѱ¹»çȸº¹Áöȸ°ü ¸£³×»ó½ºÅ¸¿ö)
l »ç¾÷ÀÚµî·Ï¹øÈ£:209-82-62797   l   ´ëÇ¥: À̽¼÷   l   e-mail: cytopathology@hanmail.net   l   tel : 02-593-6943   l   fax: 02-593-6944  
l   °³ÀÎÁ¤º¸Ã³¸®¹æħ   l   À̸ÞÀϹ«´Ü¼öÁý°ÅºÎ   l   Copyright (c) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ ALL RIGHT RESERVED.